title: Safe and effective use of outpatient non-myeloablative allogeneic stem cell transplantation for myeloma.
authors.affiliation: 1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Department of Clinical Haematology, Andrew Love Cancer Centre, Barwon Health - The Geelong Hospital, Geelong, Victoria, Australia [3] Deakin University School of Medicine, Waurn Ponds, Victoria, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Campbell
authors.affiliation: 1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
authors.forename: P
authors.initials: P
authors.lastname: Walker
authors.affiliation: 1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Avery
authors.affiliation: 1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
authors.forename: S
authors.initials: S
authors.lastname: Patil
authors.affiliation: 1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
authors.forename: D
authors.initials: D
authors.lastname: Curtis
authors.affiliation: 1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Schwarer
authors.affiliation: 1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Wei
authors.affiliation: 1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Kalff
authors.affiliation: Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia.
authors.forename: J
authors.initials: J
authors.lastname: Muirhead
authors.affiliation: 1] Malignant Haematology and Stem Cell Transplantation Service, The Alfred Hospital, Commercial Road, Prahran, Victoria, Australia [2] Australian Centre for Blood Diseases, Monash University, Clayton, Victoria, Australia.
authors.forename: A
authors.initials: A
authors.lastname: Spencer
mesh_terms: D000328:Adult; D000368:Aged; D015331:Cohort Studies; D018572:Disease-Free Survival; D005260:Female; D018380:Hematopoietic Stem Cell Transplantation / Q000379:methods*; D006801:Humans; D008297:Male; D008875:Middle Aged; D009101:Multiple Myeloma / Q000628:therapy*; D010045:Outpatients; D015996:Survival Rate; D019172:Transplantation Conditioning / Q000379:methods